Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Pain 9Neoplasms 7Agnosia 5Multiple Myeloma 4Hodgkin Disease 4Pain, Postoperative 3Lymphoma, Non-Hodgkin 3Lymphoma 3Lung Neoplasms 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Cancer Pain 3Breast Neoplasms 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Philadelphia Chromosome 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Leukemia, Myeloid, Acute 2Carcinoma in Situ 2Burkitt Lymphoma 2Acute Pain 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1

Interventions

fludarabine phosphate 5Mycophenolic Acid 5Cyclosporine 5Whole-Body Irradiation 4Peripheral Blood Stem Cell Transplantation 4Therapeutics 3midostaurin 2avapritinib 2Psychiatric Rehabilitation 2Early Intervention, Educational 2Darbepoetin alfa 2thymoglobulin 1ripretinib 1liposomal doxorubicin 1hydrocortisone valerate 1ferrous sulfate 1ferric gluconate 1denileukin diftitox 1Sunitinib 1Sucrose 1Rituximab 1Pemetrexed 1Music Therapy 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Methotrexate 1Massage 1MK 2206 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Mast-Cell × Acetaminophen × Clear all
NCT00186628 2017-11-28

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Stanford University

Phase 2 Completed
36 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Mast-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡